Becton Dickinson Declares $.22 Quarterly Dividend

genomeweb
360dx

Becton Dickinson Declares $.22 Quarterly Dividend

May 24, 2006

NEW YORK, May 23 (GenomeWeb News) - Becton Dickinson's board of directors declared a quarterly dividend of $0.215 per common share, the company said yesterday.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

Bristol-Myers Squibb, Boston Medical Center Partner to Study Immuno-Oncology Response, Resistance
OncoImmunity Wins €2.2M in European Funding for Neoantigen Prediction Tech
Autism, Developmental Delay Gene Candidates Compiled From De Novo Variant, CNV Data
Mobidiag, Autobio Diagnostics to Form Joint Venture in China
Top Five Articles on GenomeWeb Last Week: 10x Genomics, Exosome Dx, Guardant Health, and More
Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance

The Scan

Corn's Complex Path

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

This Week in PLOS

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

Five and Gone

CNBC reports that half of academic researchers leave after about five years.

From Within the Swamp

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.

Main menu